[1]
de Souza, M.P., Franceschi, F.L.S., Duarte, F.B., Coutinho, D., Duarte, B.A., Lemes, R.P.G. and Colturato, V. 2020. ARE WE READY TO INDICATE MYELODYSPLASTIC SYNDROME PATIENTS TO HEMATOPOIETIC STEM CELL TRANSPLANTATION BASED ON THEIR GENETIC STATUS?. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 1, 3 (Oct. 2020), 16–19. DOI:https://doi.org/10.46765/2675-374X.2020v2n1p16-19.